Biography
- Attending Physician, Hematology, Oncology, Neuro-Oncology, and Stem Cell Transplantation, Ann & Robert H. Lurie Children’s Hospital of Chicago
- Assistant Professor of Pediatrics (Hematology, Oncology, and Stem Cell Transplantation), Northwestern University Feinberg School of Medicine
See Lurie Children's Provider Profile
Elizabeth Sokol, MD, specializes in pediatric solid tumor care. She is part of the Children’s Oncology Group Neuroblastoma Committee and the Developmental Therapeutics Committee. Her research centers around optimizing therapeutic options for children with relapsed and refractory tumors. Additionally, she is a part of the Pharmacogenomics Steering Committee at Ann & Robert H. Lurie Children’s Hospital of Chicago, and is working to improve utilization of pharmacogenomics and expand knowledge of the impact of pharmacogenomics in pediatrics.
Education and Background
- Postdoctoral in clinical pharmacology and pharmacogenomics, University of Chicago 2018
- Fellowship in pediatric hematology and oncology, University of Chicago 2014-2017
- Residency in pediatrics, University of Chicago 2011-2014
- MD, University of Illinois at Chicago 2011
Research Highlights
UTILIZATION OF A PHARMACOGENOMICS APPROACH TO DECREASE INCIDENCE OF VINCRISTINE-ASSOCIATED PERIPHERAL NEUROPATHY IN PEDIATRIC ONCOLOGY PATIENTS
The purpose of this study is to examine the connection between a known genetic polymorphism and severe vincristine-related neuropathy in patients with a variety of pediatric cancers. The research team will then aim to introduce an intervention to decrease rates of neuropathy in order to optimize tolerance of planned chemotherapy and decrease long-term side effects of treatment.
